161 related articles for article (PubMed ID: 21454239)
21. [CDC73 mutations in young patients with primary hyperparathyroidism: A description of two clinical cases].
Mamedova EO; Mokrysheva NG; Pigarova EA; Przhiyalkovskaya EG; Voronkova IA; Vasilyev EV; Petrov VM; Gorbunova VA; Rozhinskaya LY; Belaya ZE; Tyulpakov AN
Ter Arkh; 2016; 88(10):57-62. PubMed ID: 27801421
[TBL] [Abstract][Full Text] [Related]
22. A germline mutation of HRPT2/CDC73 (70 G>T) in an adolescent female with parathyroid carcinoma: first case report and a review of the literature.
Serrano-Gonzalez M; Shay S; Austin J; Maceri DR; Pitukcheewanont P
J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1005-12. PubMed ID: 27544721
[TBL] [Abstract][Full Text] [Related]
23. Parathyroid carcinoma: etiology, diagnosis, and treatment.
Okamoto T; Iihara M; Obara T; Tsukada T
World J Surg; 2009 Nov; 33(11):2343-54. PubMed ID: 19350316
[TBL] [Abstract][Full Text] [Related]
24. Surgical treatment of parathyroid carcinoma (Review).
Hoelting T; Weber T; Werner J; Herfarth C
Oncol Rep; 2001; 8(4):931-4. PubMed ID: 11410812
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and treatment of patients with parathyroid carcinoma: an update and review.
Obara T; Fujimoto Y
World J Surg; 1991; 15(6):738-44. PubMed ID: 1767540
[TBL] [Abstract][Full Text] [Related]
26. Surgical resection of metastatic parathyroid carcinoma.
Flye MW; Brennan MF
Ann Surg; 1981 Apr; 193(4):425-35. PubMed ID: 7212805
[TBL] [Abstract][Full Text] [Related]
27. Hyperparathyroidism-jaw tumor syndrome.
Kutcher MR; Rigby MH; Bullock M; Trites J; Taylor SM; Hart RD
Head Neck; 2013 Jun; 35(6):E175-7. PubMed ID: 22302605
[TBL] [Abstract][Full Text] [Related]
28. CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum.
Frank-Raue K; Haag C; Schulze E; Keuser R; Raue F; Dralle H; Lorenz K
Eur J Endocrinol; 2011 Sep; 165(3):477-83. PubMed ID: 21652691
[TBL] [Abstract][Full Text] [Related]
29. Surgical approaches in hereditary endocrine tumors.
Iacobone M; Citton M; Viel G; Schiavone D; Torresan F
Updates Surg; 2017 Jun; 69(2):181-191. PubMed ID: 28455835
[TBL] [Abstract][Full Text] [Related]
30. Preliminary exploration of potential molecular therapeutic targets in recurrent and metastatic parathyroid carcinomas.
Cui M; Hu Y; Bi Y; Wang W; Wang M; Zhang X; Zhang R; Wang P; Su Z; Gao X; Wang J; Li Q; Liao Q; Zhao Y
Int J Cancer; 2019 Feb; 144(3):525-532. PubMed ID: 30362515
[TBL] [Abstract][Full Text] [Related]
31. Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation.
Shibata Y; Yamazaki M; Takei M; Uchino S; Sakurai A; Komatsu M
Endocr J; 2015; 62(7):627-32. PubMed ID: 25959515
[TBL] [Abstract][Full Text] [Related]
32. [Parathyroid carcinoma].
Krysiak R; Okopień B
Pol Merkur Lekarski; 2007 Aug; 23(134):145-50. PubMed ID: 18044348
[TBL] [Abstract][Full Text] [Related]
33. Genetics and Epigenetics of Parathyroid Carcinoma.
Marini F; Giusti F; Palmini G; Perigli G; Santoro R; Brandi ML
Front Endocrinol (Lausanne); 2022; 13():834362. PubMed ID: 35282432
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature.
Christakis I; Busaidy NL; Cote GJ; Williams MD; Hyde SM; Silva Figueroa AM; Kwatampora LJ; Clarke CN; Qiu W; Lee JE; Perrier ND
Int J Surg; 2016 Jul; 31():10-6. PubMed ID: 27212590
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance.
Guarnieri V; Scillitani A; Muscarella LA; Battista C; Bonfitto N; Bisceglia M; Minisola S; Mascia ML; D'Agruma L; Cole DE
J Clin Endocrinol Metab; 2006 Aug; 91(8):2827-32. PubMed ID: 16720667
[TBL] [Abstract][Full Text] [Related]
36. Primary hyperparathyroidism in MEN 1--how radical should surgery be?
Hubbard JG; Sebag F; Maweja S; Henry JF
Langenbecks Arch Surg; 2002 Mar; 386(8):553-7. PubMed ID: 11914930
[TBL] [Abstract][Full Text] [Related]
37. Current concepts in parathyroid carcinoma: a single Centre experience.
Ferraro V; Sgaramella LI; Di Meo G; Prete FP; Logoluso F; Minerva F; Noviello M; Renzulli G; Gurrado A; Testini M
BMC Endocr Disord; 2019 May; 19(Suppl 1):46. PubMed ID: 31142320
[TBL] [Abstract][Full Text] [Related]
38. Parathyroid carcinoma: Challenges in diagnosis and treatment.
Betea D; Potorac I; Beckers A
Ann Endocrinol (Paris); 2015 May; 76(2):169-77. PubMed ID: 25910997
[TBL] [Abstract][Full Text] [Related]
39. Complete genomic landscape of a recurring sporadic parathyroid carcinoma.
Kasaian K; Wiseman SM; Thiessen N; Mungall KL; Corbett RD; Qian JQ; Nip KM; He A; Tse K; Chuah E; Varhol RJ; Pandoh P; McDonald H; Zeng T; Tam A; Schein J; Birol I; Mungall AJ; Moore RA; Zhao Y; Hirst M; Marra MA; Walker BA; Jones SJ
J Pathol; 2013 Jul; 230(3):249-60. PubMed ID: 23616356
[TBL] [Abstract][Full Text] [Related]
40. Parathyroid Carcinoma.
Cetani F; Pardi E; Marcocci C
Front Horm Res; 2019; 51():63-76. PubMed ID: 30641523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
